세계의 안검성형술 시장 보고서(2025년)
Blepharoplasty Global Market Report 2025
상품코드 : 1824599
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,448,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,320,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,193,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

안검성형술 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 연평균 복합 성장률(CAGR) 8.5%를 나타내 62억 8,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 가처분소득 증가, 문화적·사회적 요인, 수술의 커스터마이즈화, 의료 투어리즘, 액세스의 용이함 등에 기인한다고 생각됩니다. 예측 기간 중 주요 동향으로는 자연스럽고 젊음의 마무리에 대한 주목, 정밀도와 안전성을 위한 기술의 통합, 콤비네이션 시술의 출현, 민족 특유의 안검성형술에 대한 수요 증가, 비외과적 선택의 역할의 증대 등을 들 수 있습니다.

향후 5년간의 성장률 8.5%라고 하는 예측은 전회 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 타국 간의 관세의 영향 때문입니다. 관세의 부과는 한국과 스웨덴에서 수입되는 정밀한 눈꺼풀 수술 기구 및 미용 충전제에 대한 접근을 제한함으로써 미국의 눈 형성 수술에 심각한 과제를 초래할 수 있으며, 미적 결과를 손상시키며 수술 비용을 상승시킬 수 있습니다. 또한 상호 관세와 무역 긴장 증가와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더 광범위하게 늘어날 것으로 보입니다.

미용 수술에 대한 수요 증가는 미래의 안검성형술 시장 성장을 이끌 것으로 예측됩니다. 미용 성형 수술은 미적 이유로 개인의 외모를 개선하거나 수정하기 위해 수행되는 의료 절차입니다. 안검성형술과 같은 시술은 눈꺼풀의 외형을 개선하고, 과다한 피부, 처진 피부(피부 숙립종), 붓기 외형의 원인이 되는 지방 침착 등, 상부 눈꺼풀의 고민에 대처할 수 있습니다. 예를 들어 미국을 거점으로 하는 국제미용정형외과학회는 2023년 9월, 2022년에 성형외과의사가 세계에서 실시한 수술건수는 1,490만건 이상, 비수술건수는 1,880만건 이상으로, 합계 11.2% 증가했다고 보고했습니다. 이와 같이 미용 성형에 대한 수요 증가는 안검성형술 시장 확대를 뒷받침할 것으로 보입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Blepharoplasty is a surgical procedure designed to enhance the aesthetics of the eyelids by eliminating surplus skin, muscle, and fat from both the upper and lower eyelids. This surgery serves dual purposes, addressing cosmetic concerns and functional issues related to impaired vision caused by drooping eyelids.

The primary types of blepharoplasty include upper eyelid blepharoplasty, lower eyelid blepharoplasty, and combination eyelid surgery. Upper eyelid blepharoplasty involves the surgical removal of excess skin, muscle, and fat from the upper eyelids, resulting in a rejuvenated appearance by eliminating redundant tissue and creating a more refreshed look. Blepharoplasty procedures are conducted on individuals of both genders, with end-users comprising hospitals, clinics, ambulatory surgical centers, and other medical facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The blepharoplasty market research report is one of a series of new reports from The Business Research Company that provides blepharoplasty market statistics, including blepharoplasty industry global market size, regional shares, competitors with a blepharoplasty market share, detailed blepharoplasty market segments, market trends and opportunities, and any further data you may need to thrive in the blepharoplasty industry. This blepharoplasty market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blepharoplasty market size has grown strongly in recent years. It will grow from $4.2 billion in 2024 to $4.54 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to aesthetic preferences and beauty standards, aging population demographics, increased awareness and acceptance, media, and celebrity influence.

The blepharoplasty market size is expected to see strong growth in the next few years. It will grow to $6.28 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to rising disposable income, cultural and social factors, customization of procedures, medical tourism, and accessibility. Major trends in the forecast period include focus on natural and youthful results, integration of technology for precision and safety, emergence of combination procedures, increased demand for ethnic-specific blepharoplasty, growing role of non-surgical alternatives.

The forecast of 8.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. oculoplastic surgery by restricting access to precision eyelid surgical instruments and cosmetic fillers imported from South Korea and Sweden, potentially compromising aesthetic outcomes and raising procedure costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising demand for cosmetic surgeries is anticipated to drive the growth of the blepharoplasty market in the future. Cosmetic surgeries are medical procedures conducted to enhance or modify an individual's physical appearance for aesthetic reasons. Procedures like blepharoplasty enable individuals to improve the look of their eyelids and address concerns with the upper eyelids, including excess skin, drooping skin (dermatochalasis), and fat deposits that cause a puffy appearance. For example, in September 2023, the International Society of Aesthetic Plastic Surgery, a US-based organization, reported that in 2022, plastic surgeons performed over 14.9 million surgical and 18.8 million non-surgical procedures globally, reflecting a total increase of 11.2%. Thus, the growing demand for cosmetic surgeries is set to boost the expansion of the blepharoplasty market.

The increasing prevalence of renal disease is forecasted to drive growth within the blepharoplasty market moving forward. Renal disease, also known as chronic kidney disease (CKD), involves the gradual loss of kidney function. This medical condition can manifest in symptoms such as eye puffiness and altered eyelid positions, potentially affecting individuals considering blepharoplasty surgery. Notably, patients with renal disease should undergo renal function assessments before opting for blepharoplasty procedures. As highlighted by the National Institutes of Health in May 2023, approximately 808,000 individuals in the United States are currently managing end-stage renal disease (ESRD), with 69% undergoing dialysis and 31% having received a kidney transplant. This prevalence of renal disease contributes to the increased demand for blepharoplasty, driving growth within the market catering to such medical needs.

Leading companies operating within the blepharoplasty market are strategically prioritizing the development of cutting-edge technologies, such as plasma technology, to strengthen their market position. Plasma technology involves utilizing ionized gases (plasmas) through specialized medical devices for non-surgical skin tightening and rejuvenation, particularly in areas such as the eyelids and facial regions. For example, in January 2023, Apyx Medical Corporation, a renowned US-based advanced energy technology company, introduced the latest-generation Renuvion generator, named the Apyx One Console. This multifunctional energy system is tailored for plastic and cosmetic surgeries, integrating Renuvion technology comprising helium plasma and radiofrequency technology, alongside monopolar and bipolar energy options. The console incorporates adaptive touchscreens, procedural presets, cloud connectivity, remote upgrade capabilities, gas volume monitoring, and other advanced features aimed at enhancing cosmetic surgical procedures, including eyelid surgery, thereby paving the way for more effective and advanced treatment options in the market.

In February 2023, Athenix, a prominent US-based medical practice company specializing in plastic surgery procedures, completed the acquisition of Marina Plastic Surgery and MedSpa for an undisclosed sum. This strategic move by Athenix is geared towards broadening its footprint within the plastic surgery sector while enhancing its range of services. The acquisition aligns with Athenix's strategic goals of expanding its offerings and strengthening its position in the plastic surgery industry. By integrating Marina Plastic Surgery and MedSpa into its portfolio, Athenix aims to reinforce its commitment to delivering comprehensive and innovative plastic surgery solutions. This strategic acquisition further solidifies Athenix's reputation as a trusted and reputable provider in the industry. Marina Plastic Surgery and MedSpa, the acquired entity, specializes in providing plastic surgery services, with a particular focus on offering blepharoplasty procedures.

Major companies operating in the blepharoplasty market report are Zimmer Biomet Holdings Inc., Cynosure Technologies Pvt Ltd., Galderma SA, Bausch & Lomb Incorporated., Allergan Inc., Integra LifeSciences Inc., Merz Pharma GmbH & Co. KGaA, Corza Ophthalmology, Lumenis Ltd., Cutera Inc., Stille AB, Alma Lasers Ltd., Sciton Inc., Beaver-Visitec International Holdings Inc., Sklar Surgical Instruments, Hayden Medical Inc., Gulmaher Surgico, Titan Medical Inc., Luminera Derm Ltd., Jedmed Instrument Company., Xelpov Surgical, Surgitrac Instruments UK Limited, Grand Aespio Inc., Surgical Holdings, Surgipro Inc., LightScalpel Inc., SPIRAL Surgical Co., Carnegie Surgical LLC., Ambler Surgical LLC

North America was the largest region in the blepharoplasty market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blepharoplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the blepharoplasty market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The blepharoplasty market consists of revenues earned by entities by providing transconjunctival blepharoplasty, canthoplasty, and revision blepharoplasty. The market value includes the value of related goods sold by the service provider or included within the service offering. The blepharoplasty market also includes sales of implants, eyelid cleansers and solutions, eyelid tape, and strips. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blepharoplasty Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blepharoplasty market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for blepharoplasty ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blepharoplasty market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Blepharoplasty Market Characteristics

3. Blepharoplasty Market Trends And Strategies

4. Blepharoplasty Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Blepharoplasty Growth Analysis And Strategic Analysis Framework

6. Blepharoplasty Market Segmentation

7. Blepharoplasty Market Regional And Country Analysis

8. Asia-Pacific Blepharoplasty Market

9. China Blepharoplasty Market

10. India Blepharoplasty Market

11. Japan Blepharoplasty Market

12. Australia Blepharoplasty Market

13. Indonesia Blepharoplasty Market

14. South Korea Blepharoplasty Market

15. Western Europe Blepharoplasty Market

16. UK Blepharoplasty Market

17. Germany Blepharoplasty Market

18. France Blepharoplasty Market

19. Italy Blepharoplasty Market

20. Spain Blepharoplasty Market

21. Eastern Europe Blepharoplasty Market

22. Russia Blepharoplasty Market

23. North America Blepharoplasty Market

24. USA Blepharoplasty Market

25. Canada Blepharoplasty Market

26. South America Blepharoplasty Market

27. Brazil Blepharoplasty Market

28. Middle East Blepharoplasty Market

29. Africa Blepharoplasty Market

30. Blepharoplasty Market Competitive Landscape And Company Profiles

31. Blepharoplasty Market Other Major And Innovative Companies

32. Global Blepharoplasty Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blepharoplasty Market

34. Recent Developments In The Blepharoplasty Market

35. Blepharoplasty Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기